Paul J. Clancy

2014

In 2014, Paul J. Clancy earned a total compensation of $4.7M as EVP, Chief Financial Officer at Biogen, a 5% increase compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$25,454
Non-Equity Incentive Plan$811,632
Salary$698,389
Stock Awards$2,824,497
Other$330,045
Total$4,690,017

Clancy received $2.8M in stock awards, accounting for 60% of the total pay in 2014.

Clancy also received $25.5K of change in pension value and nonqualified deferred compensation earnings, $811.6K in non-equity incentive plan, $698.4K in salary and $330K in other compensation.

Rankings

In 2014, Paul J. Clancy's compensation ranked 1,713th out of 13,032 executives tracked by ExecPay. In other words, Clancy earned more than 86.9% of executives.

ClassificationRankingPercentile
All
1,713
out of 13,032
87th
Division
Manufacturing
612
out of 4,965
88th
Major group
Chemicals And Allied Products
192
out of 1,690
89th
Industry group
Drugs
149
out of 1,369
89th
Industry
Biological Products, Except Diagnostic Substances
21
out of 241
91st
Source: SEC filing on April 15, 2016.

Clancy's colleagues

We found seven more compensation records of executives who worked with Paul J. Clancy at Biogen in 2014.

2014

George Scangos

Biogen

Chief Executive Officer

2014

Alfred Sandrock

Biogen

Chief Medical Officer

2014

Adriana Karaboutis

Biogen

EVP, Technology and Business Solutions

2014

Adam Koppel

Biogen

SVP, Chief Strategy Officer

2014

Douglas Williams

Biogen

Former EVP, Research and Development

2014

John Cox

Biogen

EVP, Pharmaceutical Operations and Technology

2014

Stuart Kingsley

Biogen

Former EVP, Global Operations

You may also like